Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate–severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial

Parambir S. Dulai, Jay C. Buckey, Laura E. Raffals, Jason M. Swoger, Paul L. Claus, Kevin O’Toole, Judy A. Ptak, Michael W. Gleeson, Christella E. Widjaja, John T. Chang, Jeffery M. Adler, Nihal Patel, Laurie A. Skinner, Shawn P. Haren, Kimberly Goldby-Reffner, Kimberly D. Thompson, Corey A. Siegel

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate–severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences